中文名称: | (3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二氧并[4,5-E][1,3,2]二氧磷-6-YL)二甲胺 |
中文同义词: | (3AR,8AR)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二噁唑并[4,5-E][1,3,2]二噁膦杂庚英-6-基)二甲胺;(3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二唑并[4,5-E][1,3,2]二磷杂庚英-6-基)二甲基胺;(3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二噁唑并[4,5-E][1,3,2]二噁磷杂庚英-6-基)二甲基胺;(3AR,8AR)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE(3AR,8AR)-(2,2-二;(3AR,8AR)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二噁唑并[4,5-E][1,3,2]二噁膦杂庚英-6-基)二甲胺 100MG;(3AR,8AR)-四氢-N,N,2,2-四甲基-4,4,8,8-四苯基-1,3-二恶茂并[4,5-E][1,3,2]二氧磷杂七环-6-胺;(3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二氧并[4,5-E][1,3,2]二氧磷-6-YL)二甲胺;(3AR,8AR)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二恶唑并[4,5-E][1,3,2]二噁磷杂庚英-6-基)二甲胺 |
英文名称: | (3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE |
英文同义词: | (3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE;(3aR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TET&;(3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine,min.98%;(3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine, min. 98%;(3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5- e][1,3,2]dioxaphosphepin-6-yl)dimethylamine, min. 98%;(3AR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosph;(11aR)-(+)-10,11,12,13-Tetrahydro-5-(1,1-diMethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (R)-FuP-tBu;(3aR,8aR)-Tetrahydro-N,N,2,2-tetramethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine |
CAS号: | 213843-90-4 |
分子式: | C33H34NO4P |
分子量: | 539.6 |
EINECS号: | |
Mol文件: | 213843-90-4.mol |